ROCKVILLE, MD, October 16, 2023 – AIM-HI Accelerator Fund is pleased to announce that the winners of the 2023 Women’s Venture Competition are March Biosciences and its CEO, Sarah Hein, Ph.D., as the First Prize with Distinction and Degron Therapeutics and its Co-founder and CEO, Lily Zou, Ph.D., MBA as the Second Prize. Blue-ribbon judge committee members selected them from a pool of 71 female-led, early-stage oncology companies across 15 countries.